Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Recruiting Observational Study
Bacterial Sepsis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
171 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Le…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * For all groups: patients older than 18 years at inclusion and acceptation of participation by the patient, his relative or his legal representative (depending on the situation) * For groups 1, 2, 3 and 5: Patient with a confirmed sepsis (microbiological confirmation) * For gro…
Contacts

Frédéric MARTINO, Doctor

+590 590 89 10 10

frederic.martino@chu-guadeloupe.fr

CONTACT